Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$121,439,199
-$105,072,938 QoQ
Shares Held
482,591
-53.7% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
1.08%
of 13F equity value
Holder Rank
#229
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Artemis Investment Management LLP holds $978,265,315 across 7 Drug Manufacturers - General names. ABBV ranks #5 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,279,269 | $242,574,987 | |
| 2 | PFE |
Pfizer Inc
|
7,612,597 | $183,311,335 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
3,053,480 | $175,941,517 | |
| 4 | BIIB |
Biogen Inc.
|
570,974 | $123,364,642 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
482,591 | $121,439,199 | |
| 6 | LLY |
ELI LILLY & Co
|
95,948 | $115,082,919 | |
| 7 | JNJ |
Johnson & Johnson
|
65,168 | $16,550,716 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $121,439,199 | 482,591 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $226,512,137 | 1,041,483 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $160,856,503 | 703,998 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $181,226,589 | 782,701 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $125,960,989 | 678,596 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $118,747,555 | 566,760 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $85,976,057 | 483,827 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $13,031,310 | 65,988 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $57,165,557 | 333,288 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $82,428,111 | 452,653 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $67,828,819 | 437,690 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $57,849,440 | 388,095 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $40,615,301 | 301,457 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $82,687,530 | 518,840 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $73,901,020 | 457,280 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $50,450,612 | 375,908 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $76,621,506 | 500,271 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $77,821,391 | 480,053 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $54,081,874 | 399,423 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $40,277,363 | 373,388 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $48,632,432 | 431,751 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $67,340,003 | 622,251 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $77,897,085 | 726,991 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $40,514,842 | 462,551 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $60,158,322 | 612,735 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $70,412,664 | 924,172 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||